202 related articles for article (PubMed ID: 37037709)
1. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Dold C; Zhu H; Silva-Reyes L; Blackwell L; Linder A; Bewley K; Godwin K; Fotheringham S; Charlton S; Kim YC; Pollard AJ; Rollier CS
Vaccine; 2023 May; 41(19):3047-3057. PubMed ID: 37037709
[TBL] [Abstract][Full Text] [Related]
2. Multivalent vaccines demonstrate immunogenicity and protect against
Jan S; Fratzke AP; Felgner J; Hernandez-Davies JE; Liang L; Nakajima R; Jasinskas A; Supnet M; Jain A; Felgner PL; Davies DH; Gregory AE
Front Immunol; 2023; 14():1192821. PubMed ID: 37533862
[TBL] [Abstract][Full Text] [Related]
3. Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.
Peng Y; Zhang Y; Mitchell WJ; Zhang G
J Immunol; 2012 Nov; 189(10):4909-20. PubMed ID: 23053512
[TBL] [Abstract][Full Text] [Related]
4. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
[TBL] [Abstract][Full Text] [Related]
5. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X
Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436
[TBL] [Abstract][Full Text] [Related]
6. Soluble antigens derived from
Gregory AE; van Schaik EJ; Fratzke AP; Russell-Lodrigue KE; Farris CM; Samuel JE
Cell Rep Med; 2021 Dec; 2(12):100461. PubMed ID: 35028605
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of
Sluder AE; Raju Paul S; Moise L; Dold C; Richard G; Silva-Reyes L; Baeten LA; Scholzen A; Reeves PM; Pollard AJ; Garritsen A; Bowen RA; De Groot AS; Rollier C; Poznansky MC
Front Immunol; 2022; 13():901372. PubMed ID: 35651616
[TBL] [Abstract][Full Text] [Related]
8. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
Front Immunol; 2021; 12():653092. PubMed ID: 33815413
[TBL] [Abstract][Full Text] [Related]
9. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
[TBL] [Abstract][Full Text] [Related]
10. Promiscuous
Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
Front Immunol; 2019; 10():207. PubMed ID: 30828331
[No Abstract] [Full Text] [Related]
11. The Feasibility of Using
Kumaresan V; Alam S; Zhang Y; Zhang G
Front Immunol; 2021; 12():754690. PubMed ID: 34795669
[TBL] [Abstract][Full Text] [Related]
12. Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever.
Williams JC; Hoover TA; Waag DM; Banerjee-Bhatnagar N; Bolt CR; Scott GH
Ann N Y Acad Sci; 1990; 590():370-80. PubMed ID: 2378463
[TBL] [Abstract][Full Text] [Related]
13. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
Wilhelmsen CL; Waag DM
Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice.
Zhang G; Russell-Lodrigue KE; Andoh M; Zhang Y; Hendrix LR; Samuel JE
J Immunol; 2007 Dec; 179(12):8372-80. PubMed ID: 18056383
[TBL] [Abstract][Full Text] [Related]
15. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
[TBL] [Abstract][Full Text] [Related]
16. A simple method for enrichment of phase I Coxiella burnetii.
Anderson MW; Binette P; Richards C; Beare PA; Heinzen RA; Long CM
J Microbiol Methods; 2023 Aug; 211():106787. PubMed ID: 37453478
[TBL] [Abstract][Full Text] [Related]
17. [Experience in vaccinating farm animals for preventing Q fever in humans].
Lisák V
Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
[TBL] [Abstract][Full Text] [Related]
18. Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.
Gregory AE; van Schaik EJ; Russell-Lodrigue KE; Fratzke AP; Samuel JE
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31501249
[No Abstract] [Full Text] [Related]
19. Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.
Ledbetter L; Cherla R; Chambers C; Zhang Y; Zhang G
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427447
[No Abstract] [Full Text] [Related]
20. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
